- Home
- AEI vs RPTX Comparison
AEI vs RPTX Comparison
Compare AEI & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEI | RPTX |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.4M | 92.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | AEI | RPTX |
|---|---|---|
| Price | $2.79 | $2.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 37.1K | ★ 1.3M |
| Earning Date | 11-14-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,108,028.00 | $11,870,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.70 | $0.89 |
| 52 Week High | $4.55 | $4.00 |
Technical Indicators
Market Signals| Indicator | AEI | RPTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.16 | 61.02 |
| Support Level | $2.68 | $2.11 |
| Resistance Level | $3.45 | $2.20 |
| Average True Range (ATR) | 0.35 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 28.22 | 62.07 |
Price Performance
Historical ComparisonAbout AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.